Eric Joseph
Stock Analyst at JP Morgan
(2.18)
# 2,666
Out of 4,707 analysts
124
Total ratings
43.75%
Success rate
-5.71%
Average return
Main Sectors:
Stocks Rated by Eric Joseph
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RVMD Revolution Medicines | Maintains: Overweight | $63 → $71 | $42.97 | +65.23% | 6 | Dec 3, 2024 | |
| TGTX TG Therapeutics | Maintains: Overweight | $30 → $43 | $31.07 | +38.42% | 4 | Nov 25, 2024 | |
| PTCT PTC Therapeutics | Maintains: Overweight | $51 → $62 | $45.46 | +36.38% | 6 | Nov 19, 2024 | |
| SEPN Septerna | Initiates: Overweight | $38 | $22.40 | +69.64% | 1 | Nov 19, 2024 | |
| CAMP Camp4 Therapeutics | Initiates: Overweight | $23 | $4.87 | +372.28% | 1 | Nov 5, 2024 | |
| WVE Wave Life Sciences | Maintains: Overweight | $13 → $17 | $13.09 | +29.87% | 2 | Oct 17, 2024 | |
| IGMS IGM Biosciences | Downgrades: Underweight | $12 → $9 | $7.10 | +26.76% | 7 | Oct 1, 2024 | |
| RLAY Relay Therapeutics | Maintains: Overweight | $23 → $21 | $4.20 | +400.00% | 5 | Sep 10, 2024 | |
| BLUE bluebird bio | Downgrades: Neutral | n/a | $8.41 | - | 2 | Aug 15, 2024 | |
| NVAX Novavax | Maintains: Underweight | $8 → $9 | $8.63 | +4.29% | 7 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $45 → $48 | $26.45 | +81.47% | 3 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $11 → $10 | $5.85 | +70.94% | 4 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $50 → $54 | $11.74 | +359.97% | 2 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $31 → $34 | $20.24 | +67.98% | 6 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.86 | - | 4 | Jul 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $16 → $15 | $2.64 | +468.18% | 4 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $12 | $7.16 | +67.71% | 4 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $15 | $3.88 | +287.10% | 1 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $34 → $47 | $39.06 | +20.33% | 2 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $6 | $3.66 | +64.16% | 4 | Jan 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $11 → $10 | $6.22 | +60.90% | 2 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $31 → $11 | $7.03 | +56.47% | 2 | Oct 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $62 → $41 | $28.71 | +42.81% | 2 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $5 | $0.59 | +740.48% | 1 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $28 → $5 | $1.05 | +378.47% | 2 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $47 → $48 | $14.00 | +242.86% | 3 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $3.16 | - | 6 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $11 | $5.76 | +90.97% | 6 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $9.72 | - | 2 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $8 | $0.66 | +1,107.91% | 2 | Feb 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $750 → $300 | $33.01 | +808.82% | 2 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $7.46 | - | 2 | Oct 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $50 | $5.09 | +882.32% | 1 | Jul 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underweight | $11 | $0.97 | +1,039.90% | 1 | Apr 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $24 → $9 | $2.29 | +293.01% | 2 | Jan 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $1.76 | - | 4 | Jan 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $42 | $2.34 | +1,694.87% | 1 | Feb 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $11 → $13 | $3.46 | +275.72% | 2 | Jan 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $35 → $11 | $2.35 | +368.09% | 3 | Nov 14, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $1.56 | - | 3 | Mar 2, 2018 |
Revolution Medicines
Dec 3, 2024
Maintains: Overweight
Price Target: $63 → $71
Current: $42.97
Upside: +65.23%
TG Therapeutics
Nov 25, 2024
Maintains: Overweight
Price Target: $30 → $43
Current: $31.07
Upside: +38.42%
PTC Therapeutics
Nov 19, 2024
Maintains: Overweight
Price Target: $51 → $62
Current: $45.46
Upside: +36.38%
Septerna
Nov 19, 2024
Initiates: Overweight
Price Target: $38
Current: $22.40
Upside: +69.64%
Camp4 Therapeutics
Nov 5, 2024
Initiates: Overweight
Price Target: $23
Current: $4.87
Upside: +372.28%
Wave Life Sciences
Oct 17, 2024
Maintains: Overweight
Price Target: $13 → $17
Current: $13.09
Upside: +29.87%
IGM Biosciences
Oct 1, 2024
Downgrades: Underweight
Price Target: $12 → $9
Current: $7.10
Upside: +26.76%
Relay Therapeutics
Sep 10, 2024
Maintains: Overweight
Price Target: $23 → $21
Current: $4.20
Upside: +400.00%
bluebird bio
Aug 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $8.41
Upside: -
Novavax
Aug 12, 2024
Maintains: Underweight
Price Target: $8 → $9
Current: $8.63
Upside: +4.29%
Aug 7, 2024
Maintains: Overweight
Price Target: $45 → $48
Current: $26.45
Upside: +81.47%
Aug 6, 2024
Maintains: Underweight
Price Target: $11 → $10
Current: $5.85
Upside: +70.94%
Aug 6, 2024
Maintains: Overweight
Price Target: $50 → $54
Current: $11.74
Upside: +359.97%
Jul 15, 2024
Maintains: Overweight
Price Target: $31 → $34
Current: $20.24
Upside: +67.98%
Jul 8, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.86
Upside: -
May 13, 2024
Maintains: Overweight
Price Target: $16 → $15
Current: $2.64
Upside: +468.18%
May 3, 2024
Maintains: Neutral
Price Target: $10 → $12
Current: $7.16
Upside: +67.71%
May 3, 2024
Maintains: Neutral
Price Target: $14 → $15
Current: $3.88
Upside: +287.10%
Feb 23, 2024
Maintains: Overweight
Price Target: $34 → $47
Current: $39.06
Upside: +20.33%
Jan 29, 2024
Upgrades: Neutral
Price Target: $6
Current: $3.66
Upside: +64.16%
Nov 13, 2023
Maintains: Neutral
Price Target: $11 → $10
Current: $6.22
Upside: +60.90%
Oct 19, 2023
Maintains: Overweight
Price Target: $31 → $11
Current: $7.03
Upside: +56.47%
Oct 11, 2023
Maintains: Overweight
Price Target: $62 → $41
Current: $28.71
Upside: +42.81%
Aug 28, 2023
Downgrades: Neutral
Price Target: $15 → $5
Current: $0.59
Upside: +740.48%
Aug 28, 2023
Downgrades: Neutral
Price Target: $28 → $5
Current: $1.05
Upside: +378.47%
Aug 10, 2023
Maintains: Overweight
Price Target: $47 → $48
Current: $14.00
Upside: +242.86%
Aug 10, 2023
Downgrades: Underweight
Price Target: n/a
Current: $3.16
Upside: -
Aug 9, 2023
Maintains: Neutral
Price Target: $10 → $11
Current: $5.76
Upside: +90.97%
Nov 29, 2022
Downgrades: Underweight
Price Target: n/a
Current: $9.72
Upside: -
Feb 9, 2022
Upgrades: Neutral
Price Target: $8
Current: $0.66
Upside: +1,107.91%
Jan 7, 2022
Downgrades: Neutral
Price Target: $750 → $300
Current: $33.01
Upside: +808.82%
Oct 8, 2021
Downgrades: Underweight
Price Target: n/a
Current: $7.46
Upside: -
Jul 12, 2021
Initiates: Neutral
Price Target: $50
Current: $5.09
Upside: +882.32%
Apr 26, 2021
Initiates: Underweight
Price Target: $11
Current: $0.97
Upside: +1,039.90%
Jan 29, 2021
Downgrades: Neutral
Price Target: $24 → $9
Current: $2.29
Upside: +293.01%
Jan 29, 2021
Downgrades: Underweight
Price Target: n/a
Current: $1.76
Upside: -
Feb 24, 2020
Initiates: Overweight
Price Target: $42
Current: $2.34
Upside: +1,694.87%
Jan 24, 2019
Upgrades: Neutral
Price Target: $11 → $13
Current: $3.46
Upside: +275.72%
Nov 14, 2018
Maintains: Neutral
Price Target: $35 → $11
Current: $2.35
Upside: +368.09%
Mar 2, 2018
Downgrades: Underweight
Price Target: n/a
Current: $1.56
Upside: -